Sex, male origin microchimerism, and mortality in a Danish cohort
European Journal of Epidemiology · 2025
DOI: 10.1007/s10654-025-01309-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Epidemiology, 2025. Verfasst von Gitte Lindved Petersen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Type 1 Diabetes Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. gitte.lindved.petersen@regionh.dk. Hauptthemen laut MEDLINE: Chimerism, Mortality. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Copenhagen University.
Abstract (Originalsprache)
We previously demonstrated that women with detectable male cells in peripheral blood – male origin microchimerism (a presumed souvenir from pregnancy) – enjoy half the risk of all-cause mortality compared with women tested negative. However, such differences are vulnerable to confounding. Also, it is unknown whether better survival in women vs. men is confined to women testing male origin microchimerism positive. In this updated analysis, we first compared the survival of positive and negative women using prognostic score weighing to minimize potential confounding. Next, we compared the survival of women tested positive and negative for male origin microchimerism to men. Women (n = 766) and men (n = 1,000) from the Diet, Cancer, and Health cohort aged 50–64 years in 1993–1997 were followed until 2017 for all-cause mortality in national Danish registers. Based on predictors of death, we calculated prognostic scores for all women and compared mortality according to male origin microchimerism status by prognostic score weighted Cox regression adjusting for potential confounding. Next, we compared mortality across positive/negative women and men. Women who tested male origin microchimerism positive versus negative had a 50% lower mortality rate (adjusted HR = 0.50 [95% CI 0.32–0.77]). Compared with men, women who tested positive had a 51% lower mortality rate (HR = 0.49 [95% confidence interval (CI) 0.38–0.61]), whereas women who tested negative had a similar rate (HR = 0.83 [95% CI 0.63–1.09]). Women who tested positive for male origin microchimerism lived longer than their counterparts who tested negative, who appeared to have a similar survival pattern to that of men.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Type 1 Diabetes Research, Steno Diabetes Center Copenhagen, Herlev, Denmark. gitte.lindved.petersen@regionh.dk.
- Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. gitte.lindved.petersen@regionh.dk.
- Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
- Unit of Epidemiology, Biostatistics and Biodemography, Department of Public Health, University of Southern Denmark, Odense, Denmark.
- Interdisciplinary Centre on Population Dynamics, University of Southern Denmark, Odense, Denmark.
- Danish Cancer Institute, Copenhagen, Denmark.
Förderung
- Copenhagen University
Zitieren
APA
Petersen, G. L., Nguyen, T. L., Lindahl-Jacobsen, R., Tjønneland, A., & Kamper-Jørgensen, M. (2025). Sex, male origin microchimerism, and mortality in a Danish cohort. European Journal of Epidemiology. https://doi.org/10.1007/s10654-025-01309-7
Vancouver
Petersen GL, Nguyen TL, Lindahl-Jacobsen R, Tjønneland A, Kamper-Jørgensen M. Sex, male origin microchimerism, and mortality in a Danish cohort. European Journal of Epidemiology. 2025. doi:10.1007/s10654-025-01309-7
BibTeX
@article{Petersen2025,
author = {Petersen, Gitte Lindved and Nguyen, Tri-Long and Lindahl-Jacobsen, Rune and Tjønneland, Anne and Kamper-Jørgensen, Mads},
title = {Sex, male origin microchimerism, and mortality in a Danish cohort},
journal = {European Journal of Epidemiology},
year = {2025},
doi = {10.1007/s10654-025-01309-7}
}
EUVIMED